MDI and DPI Drug Products
...The guidance sets forth information that should be provided to ensure continuing drug.....stability test storage conditions. Additional studies should be performed to characterize.....establish a set of criteria to which a drug substance or drug product should conform using..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=100)

Fresh Air '2000' A look at FDA's Medical Gas Requirements
...Finally, a finished drug product odor test must be performed on each container undergoing.....Drug product containers and closures play a critical role in assuring that the drug product.....However, an odor test may be performed on a vaporized sample of the liquid product..
http://www.fda.gov/cder/dmpq/freshair.htm (score=79)

Compressed Medical Gases Guideline, 2/89 (cmgg89.htm)
...63 requires that equipment used in the manufacture, processing, packing, or holding of a drug.....In the latter instance, testing the first container filled serves both as a component test and as a finished product test.....Specifications and testing procedures for CMG drug product container/closure systems should..
http://www.fda.gov/cder/guidance/cmgg89.htm (score=52)

Format and Content for the CMC Section of an Annual Report
...Regulatory specifications and analytical methods for the drug substance and drug..product should be listed.....To describe the information requested by the Center for Drug Evaluation and Research(CDER.....1) Full description of changes in test methods and limits. (2) Data demonstrating the..
http://www.fda.gov/cder/guidance/cmc1.pdf (score=42)

...In BE studies, an applicant compares the systemic exposure profile of a test drug product to that of.....The drug content of the test product cannot differ from that of the reference listed product by more than 5 percent.....For two orally administered drug products to be bioequivalent, the active drug ingredient or active moiety in the test product must..
http://www.fda.gov/cder/guidance/5356fnl.doc (score=41)

þÿ
...not complete a required finished-product test because of equipment failure. However, because we do.....PET drug product when a PET center was unable to complete a particular analytical.. test due to.....an inactive ingredient a product that is marketed as a finished drug product intended.. for intravenous administration, the PET..
http://www.fda.gov/cder/regulatory/pet/changestoprelimdraftregs-summary.PDF (score=39)

Guidance on the Packaging of Test Batches
...For liquids, the total amount of bulk product packaged should be,at a minimum, 10 percent.....To provide information concerning the processing, packaging and labeling of test..batches for Abbreviated New Drug.....validation studies are conducted prior to the marketing of a drug product to assure..that..
http://www.fda.gov/cder/mapp/5225-1.pdf (score=39)

þÿ
...18 The applicant and/or drug product manufacturer must establish the reliability of the.....process test and the drug substance test, the acceptance criterion for the in-process test.....associated acceptance criteria depend on the route of administration of the drug product and..
http://www.fda.gov/cder/guidance/3969DFT.pdf (score=79)

þÿ
...18 The applicant and/or drug product manufacturer must establish the reliability of the.....process test and the drug substance test, the acceptance criterion for the in-process test.....associated acceptance criteria depend on the route of administration of the drug product and..
http://www.fda.gov/OHRMS/DOCKETS/98fr/2003d-0571-gdl0001.pdf (score=76)

Guidance for Industry
...In an aseptic process, the drug product, container, and closure are first subjected to.....deviation is considered to have compromised the integrity of the sterility test, the test.....terminally sterilized drug product, on the other hand, undergoes a single sterilization process..
http://www.fda.gov/OHRMS/DOCKETS/98fr/1874dft.pdf (score=70)

stability guidance -draft
...this guidance to mean a batch of drug substance or drug product manufactured at the scale typically encountered.....In general, moderate and excellent stability mean little or no change in product test results for.....and the test methods used to monitor the stability of the drug product packaged in the..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=62)

PET Drug Products … Current Good Manufacturing Practice (CGMP)
...ensure that each batch of PET drug product meets its established acceptance criteria, 1201.....of false-positive results arises in the sampling and transfer of the test aliquot from the.....or lot, of a PET drug typically consists of one multiple-dose vial containing the PET drug..
http://www.fda.gov/cder/guidance/4259dft.pdf (score=59)

PET Drug Products - Current Good Manufacturing Practice (CGMP)
...Critical activities in the production and testing of a PET drug product that expose the PET drug product or the sterile surface.....The reliability of the supplier's test results can be established by conducting.....A batch of a PET drug product is a predefined quantity of the drug that has been produced to..
http://www.fda.gov/cder/guidance/4259dft.htm (score=56)

Packaging
...It should provide an adequate seal, be compatible with the drug product, and not be a source of.....A further test to supplement the mouse subchronic systemic test is the procedure for eye.....It is also possible for a component of the drug product to migrate through the walls of the..
http://www.fda.gov/cder/guidance/package.htm (score=56)

Guidance for Industry
...ensuring that the drug product provided to the patient has the appropriate identity, strength.....and approved lot, we recommend that the manufacturer test the combined product and approve.....The USP Oxygen Monograph requires a finished drug product odor test to be performed on..
http://www.fda.gov/OHRMS/DOCKETS/98fr/03d-0165-gdl0001.pdf (score=53)

Validation of Chromatographic Methods
...both drug substance and drug product.Detection limit is the lowest concentration of analyte in a sample that.....Solution stability of the drug substance or drug product after preparation..according to the test method should be evaluated according.....The components monitored include chiral or achiral drug, process impurities,residual..
http://www.fda.gov/cder/guidance/cmc3.pdf (score=53)

Q1B Photostability Testing of New Drug Substances and Products
...The extent of drug product testing should be established by assessing whether or not acceptable.....Care should be taken to ensure that the physical characteristics of the samples under test.....Testing should progress until the results demonstrate that the drug product is adequately..
http://www.fda.gov/cder/guidance/1318.htm (score=47)

HUMAN DRUG CGMP NOTES December 1998
...84, Testing and approval or rejection of components, drug product containers, and closures.....As of May, 1998, TOC is the official organic impurities test for USP pharmaceutical.....84, Testing and approval or rejection of components, drug product containers, and closures..
http://www.fda.gov/cder/hdn/cnotesd8.htm (score=44)

/a//content.14388
...Mixing, granulating, milling, molding, of components, drug product containers, formulating.....The accuracy, sensitivity, specificity, test the product for the presence of the.....Therefore, under the Federal Food, all established standards, specifications, Drug, and..
http://www.fda.gov/cder/dmpq/fr5396.pdf (score=42)

Substance
...individual batches of the drug substance used in animal and clinical testing, Drug.....relation to the amount of crude product, whether it is filtered while hot, whether a.....intermediate(s) or steps in the process to test, and the kind of testing required, are the..
http://www.fda.gov/cder/guidance/drugsub.pdf (score=41)

Las Vegas Injury Lawyer